[Fatal subfulminant hepatitis probably due to the combination benazepril-hydrochlorothiazide (Briazide)]. 2000

I Hourmand-Ollivier, and S Dargere, and D Cohen, and M P Galais, and B Mosquet, and P Rousselot, and T Dao

UI MeSH Term Description Entries
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006852 Hydrochlorothiazide A thiazide diuretic often considered the prototypical member of this class. It reduces the reabsorption of electrolytes from the renal tubules. This results in increased excretion of water and electrolytes, including sodium, potassium, chloride, and magnesium. It is used in the treatment of several disorders including edema, hypertension, diabetes insipidus, and hypoparathyroidism. Dichlothiazide,Dihydrochlorothiazide,Esidrex,Esidrix,HCTZ,HydroDIURIL,Hypothiazide,Oretic,Sectrazide
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000959 Antihypertensive Agents Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. Anti-Hypertensive,Anti-Hypertensive Agent,Anti-Hypertensive Drug,Antihypertensive,Antihypertensive Agent,Antihypertensive Drug,Anti-Hypertensive Agents,Anti-Hypertensive Drugs,Anti-Hypertensives,Antihypertensive Drugs,Antihypertensives,Agent, Anti-Hypertensive,Agent, Antihypertensive,Agents, Anti-Hypertensive,Agents, Antihypertensive,Anti Hypertensive,Anti Hypertensive Agent,Anti Hypertensive Agents,Anti Hypertensive Drug,Anti Hypertensive Drugs,Anti Hypertensives,Drug, Anti-Hypertensive,Drug, Antihypertensive,Drugs, Anti-Hypertensive,Drugs, Antihypertensive
D001552 Benzazepines Compounds with BENZENE fused to AZEPINES.
D056486 Chemical and Drug Induced Liver Injury A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment. Drug-Induced Liver Injury,Liver Injury, Drug-Induced,Acute Liver Injury, Drug-Induced,Chemically-Induced Liver Toxicity,Drug-Induced Acute Liver Injury,Drug-Induced Liver Disease,Hepatitis, Drug-Induced,Hepatitis, Toxic,Liver Injury, Drug-Induced, Acute,Toxic Hepatitis,Acute Liver Injury, Drug Induced,Chemically Induced Liver Toxicity,Chemically-Induced Liver Toxicities,Disease, Drug-Induced Liver,Diseases, Drug-Induced Liver,Drug Induced Acute Liver Injury,Drug Induced Liver Disease,Drug Induced Liver Injury,Drug-Induced Hepatitides,Drug-Induced Hepatitis,Drug-Induced Liver Diseases,Drug-Induced Liver Injuries,Hepatitides, Drug-Induced,Hepatitides, Toxic,Hepatitis, Drug Induced,Injuries, Drug-Induced Liver,Injury, Drug-Induced Liver,Liver Disease, Drug-Induced,Liver Diseases, Drug-Induced,Liver Injuries, Drug-Induced,Liver Injury, Drug Induced,Liver Toxicities, Chemically-Induced,Liver Toxicity, Chemically-Induced,Toxic Hepatitides,Toxicities, Chemically-Induced Liver,Toxicity, Chemically-Induced Liver
D017809 Fatal Outcome Death resulting from the presence of a disease in an individual, as shown by a single case report or a limited number of patients. This should be differentiated from DEATH, the physiological cessation of life and from MORTALITY, an epidemiological or statistical concept. Fatal Outcomes,Outcome, Fatal,Outcomes, Fatal

Related Publications

I Hourmand-Ollivier, and S Dargere, and D Cohen, and M P Galais, and B Mosquet, and P Rousselot, and T Dao
February 1967, JAMA,
I Hourmand-Ollivier, and S Dargere, and D Cohen, and M P Galais, and B Mosquet, and P Rousselot, and T Dao
January 1986, Gastroenterologie clinique et biologique,
I Hourmand-Ollivier, and S Dargere, and D Cohen, and M P Galais, and B Mosquet, and P Rousselot, and T Dao
January 1991, Gastroenterologie clinique et biologique,
I Hourmand-Ollivier, and S Dargere, and D Cohen, and M P Galais, and B Mosquet, and P Rousselot, and T Dao
January 1993, Gastroenterologie clinique et biologique,
I Hourmand-Ollivier, and S Dargere, and D Cohen, and M P Galais, and B Mosquet, and P Rousselot, and T Dao
October 1967, Sanfujinka no jissai. Practice of gynecology and obstetrics,
I Hourmand-Ollivier, and S Dargere, and D Cohen, and M P Galais, and B Mosquet, and P Rousselot, and T Dao
October 1984, Gastroenterologie clinique et biologique,
I Hourmand-Ollivier, and S Dargere, and D Cohen, and M P Galais, and B Mosquet, and P Rousselot, and T Dao
July 1972, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
I Hourmand-Ollivier, and S Dargere, and D Cohen, and M P Galais, and B Mosquet, and P Rousselot, and T Dao
March 2000, The American journal of gastroenterology,
I Hourmand-Ollivier, and S Dargere, and D Cohen, and M P Galais, and B Mosquet, and P Rousselot, and T Dao
January 2009, Kardiologiia,
I Hourmand-Ollivier, and S Dargere, and D Cohen, and M P Galais, and B Mosquet, and P Rousselot, and T Dao
November 2001, Journal of hypertension,
Copied contents to your clipboard!